Loading...
Loading...
Goldman Sachs reiterated its Buy rating on Calpine Corporation
CPN and increased its price target from $20 to $21.
Goldman Sachs noted, "After 2Q2012 reporting, where Calpine (CPN, Conviction Buy) reported adjusted EBITDA of $403mn versus GS/consensus of $400mn/$394mn, we update 2012-2015 EBITDA from $1.77/$2.10/$1.99/$1.90bn to $1.77/$2.12/$2.06/$1.93bn. Our higher estimates reflect (1) increased hedging levels, positive for 2014 EBITDA, (2) higher than previously assumed 2013-2015 EBITDA contribution from new California power plants and (3) modestly better-than-expected 2Q2012 results."
Calpine Corporation closed at $17.87 on Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in